BUENA, N.J., May 07, 2018 -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at Deutsche Bank’s 43rd Annual Health Care Conference. The Conference is taking place May 8-9, 2018 at the Intercontinental Hotel, Boston.
Damian Finio, Chief Financial Officer of Teligent, Inc., will present on Tuesday, May 8th at 2:10 p.m. ET.
The presentation will be webcast and accessible online via the investors section of the Company's website at www.teligent.com. A replay will be available for 30 days.
About Teligent, Inc.
Teligent is a specialty generic pharmaceutical company. Our mission is to be a leading player in the specialty generic prescription drug market. Learn more on our website www.teligent.com.
Contact:
Damian Finio
Teligent, Inc.
(856) 336-9117
www.teligent.com


Boeing Secures 50 737 MAX Jet Order from Vietnam Airlines Amid Expanding Global Demand
Texas Attorney General Ken Paxton Sues Sanofi Over Alleged Healthcare Bribery Scheme
Microsoft Plans $50 Billion AI Investment to Accelerate Growth in the Global South
Bill Gates Pulls Out of India’s AI Impact Summit Amid Controversy and Event Mismanagement
Stock Market Movers: NVIDIA and Meta Expand AI Partnership as Cadence Surges on Earnings
Qualcomm to Invest $150 Million in India AI Startups, Strengthening Presence in Growing Market
Medical Groups Sue FTC Over Gender-Affirming Care Investigations Amid Trump Policy Dispute
OpenAI Nears $100 Billion Funding Round at $850 Billion Valuation: Bloomberg Report
Yotta to Build $2 Billion AI Data Centre Hub in India with Nvidia Blackwell Ultra Chips
Freedom Finance and Binance Join Forces in Digital Assets
Hedge Funds Cut Nvidia, Amazon and Microsoft Stakes as AI Valuation Concerns Rise
Vietnam Airlines, Vietjet, and Sun PhuQuoc Airways Sign Major Boeing Aircraft Deals Amid U.S.–Vietnam Trade Talks
Mark Zuckerberg Testifies in Youth Social Media Addiction Trial Over Instagram Policies
HSBC Cuts 10% of U.S. Debt Capital Markets Team Amid Ongoing Business Revamp
NAB Shares Hit Record High as First-Quarter Cash Earnings Jump 16% 



